165 related articles for article (PubMed ID: 26321742)
1. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells.
Lin JY; Ke YM; Lai JS; Ho TF
Phytomedicine; 2015 Sep; 22(10):929-38. PubMed ID: 26321742
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
3. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
Chang CC; Lai JS; Tsai CS; Ma SW; Lin JY; Huang LR; Lu CH; Liao EC; Ho TF
J Biosci Bioeng; 2013 Oct; 116(4):516-23. PubMed ID: 23660075
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
Jiao JW; Wen F
Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA effects on ovarian cancer cell line.
Li N; Yang L; Zhang B; Chen S
J Pharm Pharmacol; 2018 Oct; 70(10):1369-1377. PubMed ID: 29943422
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis.
Liu JJ; Zhang Y; Lin DJ; Xiao RZ
Oncol Rep; 2009 Apr; 21(4):1075-81. PubMed ID: 19288011
[TBL] [Abstract][Full Text] [Related]
8. Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin.
Lee DH; Lee CS; Kim DW; Ae JE; Lee TH
Anticancer Drugs; 2014 Jan; 25(1):44-52. PubMed ID: 24045365
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway.
Maione F; De Feo V; Caiazzo E; De Martino L; Cicala C; Mascolo N
J Ethnopharmacol; 2014 Sep; 155(2):1236-42. PubMed ID: 25038434
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
11. A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells.
Lin T; Wan L; Qi X; Shi W; Lin J
Bioelectromagnetics; 2014 Jul; 35(5):337-46. PubMed ID: 24619849
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
14. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
Lu M; Wang C; Wang J
Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
[TBL] [Abstract][Full Text] [Related]
16. Novel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells.
Ma H; Fan Q; Yu J; Xin J; Zhang C
Am J Chin Med; 2013; 41(1):197-210. PubMed ID: 23336516
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure.
Li JH; Xu M; Xie XY; Fan QX; Mu DG; Zhang Y; Cao FL; Wang YX; Zhao PT; Zhang B; Jin FG; Li ZC
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):269-77. PubMed ID: 21314841
[TBL] [Abstract][Full Text] [Related]
18. Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin.
Yoon MJ; Park SS; Kang YJ; Kim IY; Lee JA; Lee JS; Kim EG; Lee CW; Choi KS
Carcinogenesis; 2012 Mar; 33(3):492-500. PubMed ID: 22159225
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells.
Xu M; Cao FL; Li NY; Liu YQ; Li YP; Lv CL
Asian Pac J Cancer Prev; 2013; 14(1):173-7. PubMed ID: 23534719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]